» Articles » PMID: 30850169

Comparative Outcomes Between Robotic and Abdominal Radical Hysterectomy for IB1 Cervical Cancer: Results from a Single High Volume Institution

Overview
Journal Gynecol Oncol
Date 2019 Mar 10
PMID 30850169
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare the perioperative morbidity and survival between abdominal radical hysterectomy (ARH) and robotic radical hysterectomy (RRH).

Methods: A retrospective cohort of patients undergoing radical hysterectomy for cervical cancer from 2010 to 2016 was identified. Patients with stage IB1 cervical cancer were included and were grouped by ARH vs. RRH. Tumor characteristics, perioperative complications, recurrence rate, progression-free survival (PFS), and overall survival (OS) were compared between groups.

Results: 105 patients were identified; 56 underwent ARH and 49 underwent RRH. Those who had ARH were more likely to have lesions that were ≥2 cm (62% vs. 39%, p = 0.02) and that were higher grade (p = 0.048). Other tumor characteristics were similar between groups. There was no difference in perioperative complication rates between groups. Additionally, there were no differences in recurrence risk (RR) (14% vs. 24%, p = 0.22), progression-free survival (PFS) (p = 0.28), or overall survival (OS) (p = 0.16). However, in those with tumors ≥2 cm there was a higher risk of recurrence in the overall cohort (30% vs. 8%, p = 0.006), and a shorter PFS in the RRH group (HR 0.31, p = 0.04). On multivariate analysis patients that underwent ARH or had tumors < 2 cm had a lower likelihood of recurrence (HR 0.38, p = 0.04; HR 0.175, p = 0.002) and death (HR 0.21, p = 0.029; HR 0.15, p = 0.02).

Conclusion: Perioperative morbidity was similar between those undergoing ARH vs. RRH for IB1 cervical cancer. Patients with tumors ≥ 2 cm undergoing RRH had a shorter PFS compared to ARH. On multivariate analysis, RRH and tumor size ≥ 2 cm were independently associated with recurrence and death in this population.

Citing Articles

Feasibility and early oncologic outcomes of Total Intracorporeal Robotic Radical Hysterectomy with Vaginal Cerclage (TIRRHVC) for the treatment of clinical stage IB cervical cancer: A tumor containment technique.

Lim L, Slee A, Lim P Gynecol Oncol Rep. 2024; 54:101437.

PMID: 39021507 PMC: 467087. DOI: 10.1016/j.gore.2024.101437.


Emerging multi-port soft tissue robotic systems: a systematic review of clinical outcomes.

Leang Y, Kong J, Mosharaf Z, Hensman C, Burton P, Brown W J Robot Surg. 2024; 18(1):145.

PMID: 38554226 PMC: 10981598. DOI: 10.1007/s11701-024-01887-w.


Robot-assisted versus conventional laparoscopic radical hysterectomy in cervical cancer stage IB1.

Kim S, Yoo J, Lee S, Park D, Yoon J Int J Med Sci. 2023; 20(3):287-291.

PMID: 36860680 PMC: 9969504. DOI: 10.7150/ijms.79830.


The RECOURSE Study: Long-term Oncologic Outcomes Associated With Robotically Assisted Minimally Invasive Procedures for Endometrial, Cervical, Colorectal, Lung, or Prostate Cancer: A Systematic Review and Meta-analysis.

Leitao Jr M, Kreaden U, Laudone V, Park B, Pappou E, Davis J Ann Surg. 2022; 277(3):387-396.

PMID: 36073772 PMC: 9905254. DOI: 10.1097/SLA.0000000000005698.


Clavien-Dindo classification and risk prediction model of complications after robot-assisted radical hysterectomy for cervical cancer.

Ling H, Wang G, Yi B, Li Z, Zhu S J Robot Surg. 2022; 17(2):527-536.

PMID: 35913623 DOI: 10.1007/s11701-022-01450-5.


References
1.
Cantrell L, Mendivil A, Gehrig P, Boggess J . Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience. Gynecol Oncol. 2010; 117(2):260-5. DOI: 10.1016/j.ygyno.2010.01.012. View

2.
Brudie L, Backes F, Ahmad S, Zhu X, Finkler N, Bigsby 4th G . Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgery. Gynecol Oncol. 2012; 128(2):309-15. DOI: 10.1016/j.ygyno.2012.11.005. View

3.
Sert B, Boggess J, Ahmad S, Jackson A, Stavitzski N, Dahl A . Robot-assisted versus open radical hysterectomy: A multi-institutional experience for early-stage cervical cancer. Eur J Surg Oncol. 2016; 42(4):513-22. DOI: 10.1016/j.ejso.2015.12.014. View

4.
SEDLIS A, Bundy B, ROTMAN M, Lentz S, Muderspach L, Zaino R . A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol. 1999; 73(2):177-83. DOI: 10.1006/gyno.1999.5387. View

5.
Walker J, Piedmonte M, Spirtos N, Eisenkop S, Schlaerth J, Mannel R . Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol. 2009; 27(32):5331-6. PMC: 2773219. DOI: 10.1200/JCO.2009.22.3248. View